Royal Bank of Canada
ANAB icon

Royal Bank of Canada’s AnaptysBio ANAB Stock Holding History

Royal Bank of Canada’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Buy
4,219
+2,501
+146% +$135K ﹤0.01% 4618
2025
Q4 		$83K Buy
1,718
+1,560
+987% +$60.8K ﹤0.01% 5291
2025
Q3 		$5K Sell
158
-1,138
-88% -$26.1K ﹤0.01% 6677
2025
Q2 		$29K Sell
1,296
-52
-4% -$1.09K ﹤0.01% 6133
2025
Q1 		$26K Buy
1,348
+126
+10% +$2.1K ﹤0.01% 5821
2024
Q4 		$17K Sell
1,222
-2,870
-70% -$69.5K ﹤0.01% 6164
2024
Q3 		$136K Buy
4,092
+2,024
+98% +$69.1K ﹤0.01% 5123
2024
Q2 		$51K Buy
2,068
+1,129
+120% +$26.3K ﹤0.01% 5648
2024
Q1 		$20K Sell
939
-6,241
-87% -$148K ﹤0.01% 5911
2023
Q4 		$154K Buy
7,180
+4,537
+172% +$78.3K ﹤0.01% 5305
2023
Q3 		$48K Buy
2,643
+1,154
+78% +$22K ﹤0.01% 5797
2023
Q2 		$31K Buy
1,489
+347
+30% +$7.04K ﹤0.01% 5987
2023
Q1 		$25K Sell
1,142
-1,148
-50% -$27.9K ﹤0.01% 5936
2022
Q4 		$71K Buy
2,290
+1,359
+146% +$38.4K ﹤0.01% 5688
2022
Q3 		$23K Buy
931
+130
+16% +$3.05K ﹤0.01% 6081
2022
Q2 		$16K Sell
801
-27,054
-97% -$599K ﹤0.01% 6191
2022
Q1 		$689K Sell
27,855
-12,211
-30% -$370K ﹤0.01% 4003
2021
Q4 		$1.39M Buy
40,066
+2,342
+6% +$74.3K ﹤0.01% 3501
2021
Q3 		$1.02M Sell
37,724
-53
-0.1% -$1.34K ﹤0.01% 3671
2021
Q2 		$979K Buy
37,777
+36,843
+3,945% +$883K ﹤0.01% 3671
2021
Q1 		$20K Buy
+934
New +$23.6K ﹤0.01% 6414
2020
Q4 		– Sell
-3
Closed – – 7046
2020
Q3 		$0 Sell
3
-43
-93% -$776 ﹤0.01% 6583
2020
Q2 		$1K Sell
46
-100
-68% -$1.83K ﹤0.01% 6374
2020
Q1 		$2K Sell
146
-1,782
-92% -$27K ﹤0.01% 6271
2019
Q4 		$32K Sell
1,928
-1,045
-35% -$24.7K ﹤0.01% 5655
2019
Q3 		$104K Buy
2,973
+465
+19% +$22.1K ﹤0.01% 4783
2019
Q2 		$141K Buy
2,508
+199
+9% +$14.3K ﹤0.01% 4684
2019
Q1 		$169K Buy
2,309
+551
+31% +$38K ﹤0.01% 4455
2018
Q4 		$112K Sell
1,758
-2,022
-53% -$150K ﹤0.01% 4665
2018
Q3 		$377K Sell
3,780
-63,126
-94% -$5.24M ﹤0.01% 4081
2018
Q2 		$4.75M Buy
66,906
+27,029
+68% +$2.27M ﹤0.01% 2043
2018
Q1 		$4.15M Buy
39,877
+37,112
+1,342% +$4.18M ﹤0.01% 2137
2017
Q4 		$279K Buy
2,765
+1,126
+69% +$82.9K ﹤0.01% 4217
2017
Q3 		$57K Buy
1,639
+1,583
+2,827% +$42.7K ﹤0.01% 5334
2017
Q2 		$1K Sell
56
-244
-81% -$6.13K ﹤0.01% 6361
2017
Q1 		$8K Buy
+300
New +$6.99K ﹤0.01% 6051

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Royal Bank of Canada's ANAB Position: Q1 2026 in Review

Royal Bank of Canada increased its AnaptysBio (ANAB) stake by 146% in Q1 2026, buying an estimated $135K and bringing the position to 4,219 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #4618.

Royal Bank of Canada first reported a position in ANAB in Q1 2017 and has held it in 36 quarters since. The position peaked at $4.75M in Q2 2018. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Royal Bank of Canada held 4,219 shares of AnaptysBio worth $234K as of Q1 2026.
  • Royal Bank of Canada bought 2,501 AnaptysBio shares in Q1 2026, an estimated $135K.
  • AnaptysBio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4618 holding.
  • Royal Bank of Canada first reported a position in AnaptysBio in Q1 2017 and has held it in 36 quarters since.
  • Royal Bank of Canada's AnaptysBio position peaked at $4.75M in Q2 2018.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.